Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Financial News

Mirum, Fulcrum file for IPOs

June 22, 2019 12:25 AM UTC

On Friday, Mirum and Fulcrum each filed to raise up to $86.3 million in NASDAQ IPOs.

Mirum Pharmaceuticals Inc. (San Francisco, Calif.) launched in November with a $120 million series A round led by New Enterprise Associates. The biotech has a license from Shire plc to a pair of SLC10A2 inhibitors to treat liver diseases (see "Mirium Launches with Liver Disease Candidates from Shire"). ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article